Asymptomatic hypoxia in COVID-19 is associated with poor outcome.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 24 09 2020
revised: 22 10 2020
accepted: 23 10 2020
pubmed: 2 11 2020
medline: 15 1 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Describe and evaluate the outcome of a coronavirus disease-2019 (COVID-19) patient without shortness of breath. We retrospectively collected data from COVID-19 patients diagnosed and cared for in Marseille, France. We selected data from patients who at admission, had a low dose CT scanner, dyspnea status, and oxygen saturation available. Blood gas was analyzed in a sample subset of patients. Among 1712 patients with COVID-19, we report that 1107 (64.7%) do not complain of shortness of breath at admission. The low-dose computed tomography (LDCT) scan showed signs compatible with pneumonia in 757/1,107 (68.4%) of patients without dyspnea. In a subset of patients who had underwent at least one blood gas analysis (n = 161) and presented without dyspnea at admission, 28.1% (27/96) presented with a hypoxemia/hypocapnia syndrome. Asymptomatic hypoxia was associated with a very poor outcome (33.3% were transferred to the ICU and 25.9% died). The absence of shortness of breath in an old patient with comorbidity merit medical attention and should not be considered as a good sign of well-being. The poor prognosis of asymptomatic hypoxia, highlight the severity of this mild clinical presentation. In these patients, pulse oximetry is an important mean to predict the outcome along with news score and LDCT scanner.

Identifiants

pubmed: 33130200
pii: S1201-9712(20)32271-2
doi: 10.1016/j.ijid.2020.10.067
pmc: PMC7604151
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-238

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
Lancet Infect Dis. 2020 Oct;20(10):1135-1140
pubmed: 32526193
Science. 2020 May 1;368(6490):455-456
pubmed: 32355007
N Engl J Med. 1988 Nov 24;319(21):1369-73
pubmed: 3185647
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA Netw Open. 2020 Apr 1;3(4):e205619
pubmed: 32275319
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Travel Med Infect Dis. 2020 Sep - Oct;37:101875
pubmed: 32898703
Tidsskr Nor Laegeforen. 2020 Apr 11;140(7):
pubmed: 32378842
Travel Med Infect Dis. 2020 Jul - Aug;36:101791
pubmed: 32593867
Intensive Care Med. 2020 Feb;46(2):357-360
pubmed: 32025779
Am J Respir Crit Care Med. 2020 Aug 1;202(3):356-360
pubmed: 32539537

Auteurs

Philippe Brouqui (P)

Aix Marseille Université, IRD, MEPHI, Marseille, France; IHU-Mediterranée Infection, Marseille, France. Electronic address: philippe.brouqui@univ-amu.fr.

Sophie Amrane (S)

Aix Marseille Université, IRD, MEPHI, Marseille, France; IHU-Mediterranée Infection, Marseille, France.

Matthieu Million (M)

Aix Marseille Université, IRD, MEPHI, Marseille, France; IHU-Mediterranée Infection, Marseille, France.

Sébastien Cortaredona (S)

IHU-Mediterranée Infection, Marseille, France; Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.

Philippe Parola (P)

IHU-Mediterranée Infection, Marseille, France; Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.

Jean-Christophe Lagier (JC)

Aix Marseille Université, IRD, MEPHI, Marseille, France; IHU-Mediterranée Infection, Marseille, France.

Didier Raoult (D)

Aix Marseille Université, IRD, MEPHI, Marseille, France; IHU-Mediterranée Infection, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH